跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 316 条关于
“CD228V”
全部
316
临床试验
146
药物
160
机构
0
资讯
10
15天前
Medicus Pharma Secures Global License from Pfizer for CD228-Targeting ADC, Valued at Over $1 Billion in Milestones
去年
Formation Bio Licenses First-in-Class Anti-CD226 Monoclonal Antibody for Autoimmune Diseases
去年
Inotuzumab Ozogamicin Plus Low-Intensity Chemo Shows Promise in Older ALL Patients
3年前
Canadian-Developed CAR T-Cell Therapy Targeting CD22 Heads to Clinical Trials
去年
Cargo Therapeutics Halts CD22 Cell Therapy Trial, Sparks Debate on Biotech Company Survival
去年
Novel CD28 x Nectin-4 Bispecific Antibody Shows Promise in Advanced Bladder Cancer Treatment
11个月前
Dual CD19/CD22 CAR-T Therapy Achieves Durable Remission in Refractory Plasmablastic Lymphoma Case
10天前
ME Therapeutics Advances In Vivo CD19/CD22 CAR and Liver-Detargeted STING mRNA Programs
去年
Bicistronic CD19/CD22 CAR T-Cell Therapy Shows Durable Responses in Pediatric B-ALL
11个月前
ME Therapeutics Secures Exclusive License for CD22 Nanobody Technology to Advance Next-Generation CAR Cell Therapies